0001213900-22-080971.txt : 20221219
0001213900-22-080971.hdr.sgml : 20221219
20221219170434
ACCESSION NUMBER: 0001213900-22-080971
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221216
FILED AS OF DATE: 20221219
DATE AS OF CHANGE: 20221219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tegge Jonathan
CENTRAL INDEX KEY: 0001755310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39685
FILM NUMBER: 221471911
MAIL ADDRESS:
STREET 1: 217 W. MAIN STREET
CITY: SOMERVILLE
STATE: NJ
ZIP: 08876
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
4
1
ownership.xml
X0306
4
2022-12-16
0
0001728328
InMed Pharmaceuticals Inc.
INM
0001755310
Tegge Jonathan
C/O INMED PHARMACEUTICALS INC.
310-815 WEST HASTINGS ST.
VANCOUVER
A1
V6C1B4
BRITISH COLUMBIA, CANADA
0
1
0
0
Interim CFO
Employee Stock Option (Right to Buy)
1.78
2022-12-16
4
A
0
1400
0.00
A
2027-12-15
Common shares
1400
1400
D
Vesting 1/12 per month, in arrears, for 12 months.
/s/ Eric A Adams, attorney-in-fact for Mr. Jonathan Tegge
2022-12-19